{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-4571"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-4571","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"Using c/µ test to investigate the coding and noncoding regions to identify selective pressures in HIV-1 virus.","abstract":"Human immunodeficiency virus type 1 (HIV-1) is a single-stranded RNA retrovirus whose error-prone reverse transcriptase drives a high mutation rate, enabling adaptive mutations on drug target proteins that confer antiviral resistance and complicate long-term treatment. This study therefore aims to detect such adaptive mutations on HIV-1 drug target proteins using our novel analysis framework (c/µ) on 5,711 genomic sequences, with findings expected to inform timely therapeutic adjustments and guide the development of more robust antiretroviral strategies. In Chapter 1, our novel mathematical framework (c/µ) and the Near Neutral Unbalanced Selection Theory (NNUST), which posits that most mutations experience weak but non-neutral selection pressures, are introduced and applied to HIV-1. Our analysis of the molecular evolution of HIV-1 revealed that the (c/µ) of each nucleotide/amino acid site can be calculated to infer the overall site-specific selection fitness of the genome. In Chapter 2, the mutation rate µ is approximated independently of genetic codon tables and Markovian models by applying two complementary approaches: a time-based method using temporal sequence data and a position-based method leveraging genome-wide substitution rates. Using this framework, the c/µ test revealed an unexpected L-shaped distribution of fitness effects (DFE) and evidence of molecular clock violation across several genomic segments over 92 years of viral evolution. In Chapter 3, application of the codon-based c/µ method identified literature-validated adaptive mutations in Reverse Transcriptase, Protease, and Integrase, demonstrating the framework's ability to detect functionally relevant drug resistance mutations. Collectively, this work establishes a quantitative, multidisciplinary framework for understanding HIV-1 molecular evolution and provides insights that may inform future antiviral strategies and drug resistance detection efforts, as further validated through case studies on SARS-CoV-2 and EV68, demonstrating the framework's broader applicability to RNA viruses.","abstract_html":"Human immunodeficiency virus type 1 (HIV-1) is a single-stranded RNA retrovirus whose error-prone reverse transcriptase drives a high mutation rate, enabling adaptive mutations on drug target proteins that confer antiviral resistance and complicate long-term treatment. This study therefore aims to detect such adaptive mutations on HIV-1 drug target proteins using our novel analysis framework (c/µ) on 5,711 genomic sequences, with findings expected to inform timely therapeutic adjustments and guide the development of more robust antiretroviral strategies. In Chapter 1, our novel mathematical framework (c/µ) and the Near Neutral Unbalanced Selection Theory (NNUST), which posits that most mutations experience weak but non-neutral selection pressures, are introduced and applied to HIV-1. Our analysis of the molecular evolution of HIV-1 revealed that the (c/µ) of each nucleotide/amino acid site can be calculated to infer the overall site-specific selection fitness of the genome. In Chapter 2, the mutation rate µ is approximated independently of genetic codon tables and Markovian models by applying two complementary approaches: a time-based method using temporal sequence data and a position-based method leveraging genome-wide substitution rates. Using this framework, the c/µ test revealed an unexpected L-shaped distribution of fitness effects (DFE) and evidence of molecular clock violation across several genomic segments over 92 years of viral evolution. In Chapter 3, application of the codon-based c/µ method identified literature-validated adaptive mutations in Reverse Transcriptase, Protease, and Integrase, demonstrating the framework&#x27;s ability to detect functionally relevant drug resistance mutations. Collectively, this work establishes a quantitative, multidisciplinary framework for understanding HIV-1 molecular evolution and provides insights that may inform future antiviral strategies and drug resistance detection efforts, as further validated through case studies on SARS-CoV-2 and EV68, demonstrating the framework&#x27;s broader applicability to RNA viruses.","abstract_has_math":false,"creators":["Tran, Annie"],"institution":null,"degree_name":"M.S. Pharmaceutical Sciences","degree_level":"Thesis","degree_discipline":"Pharmaceutical Sciences","degree_department":null,"school":null,"contributors":["Chun Wu, Ph.D.","Zhihong Wang, Ph.D.","Zwiwei Liu, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T09:00:08Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/3565","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/3565","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-4571","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Chun Wu, Ph.D.","Zhihong Wang, Ph.D.","Zwiwei Liu, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Tran, Annie"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2026-07-20T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2026-07-20T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Pharmaceutical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S. Pharmaceutical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/3565"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Human immunodeficiency virus type 1 (HIV-1) is a single-stranded RNA retrovirus whose error-prone reverse transcriptase drives a high mutation rate, enabling adaptive mutations on drug target proteins that confer antiviral resistance and complicate long-term treatment. This study therefore aims to detect such adaptive mutations on HIV-1 drug target proteins using our novel analysis framework (c/µ) on 5,711 genomic sequences, with findings expected to inform timely therapeutic adjustments and guide the development of more robust antiretroviral strategies. In Chapter 1, our novel mathematical framework (c/µ) and the Near Neutral Unbalanced Selection Theory (NNUST), which posits that most mutations experience weak but non-neutral selection pressures, are introduced and applied to HIV-1. Our analysis of the molecular evolution of HIV-1 revealed that the (c/µ) of each nucleotide/amino acid site can be calculated to infer the overall site-specific selection fitness of the genome. In Chapter 2, the mutation rate µ is approximated independently of genetic codon tables and Markovian models by applying two complementary approaches: a time-based method using temporal sequence data and a position-based method leveraging genome-wide substitution rates. Using this framework, the c/µ test revealed an unexpected L-shaped distribution of fitness effects (DFE) and evidence of molecular clock violation across several genomic segments over 92 years of viral evolution. In Chapter 3, application of the codon-based c/µ method identified literature-validated adaptive mutations in Reverse Transcriptase, Protease, and Integrase, demonstrating the framework's ability to detect functionally relevant drug resistance mutations. Collectively, this work establishes a quantitative, multidisciplinary framework for understanding HIV-1 molecular evolution and provides insights that may inform future antiviral strategies and drug resistance detection efforts, as further validated through case studies on SARS-CoV-2 and EV68, demonstrating the framework's broader applicability to RNA viruses."]},{"key":"dc:title","label":"Title","values":["Using c/µ test to investigate the coding and noncoding regions to identify selective pressures in HIV-1 virus."]}]}],"canonical_facts":{"dc:contributor":["Chun Wu, Ph.D.","Zhihong Wang, Ph.D.","Zwiwei Liu, Ph.D."],"dc:creator":["Tran, Annie"],"dc:date.available":["2026-07-20T07:00:00Z"],"dc:date.created":["2026-07-20T07:00:00Z"],"dc:description.abstract":["Human immunodeficiency virus type 1 (HIV-1) is a single-stranded RNA retrovirus whose error-prone reverse transcriptase drives a high mutation rate, enabling adaptive mutations on drug target proteins that confer antiviral resistance and complicate long-term treatment. This study therefore aims to detect such adaptive mutations on HIV-1 drug target proteins using our novel analysis framework (c/µ) on 5,711 genomic sequences, with findings expected to inform timely therapeutic adjustments and guide the development of more robust antiretroviral strategies. In Chapter 1, our novel mathematical framework (c/µ) and the Near Neutral Unbalanced Selection Theory (NNUST), which posits that most mutations experience weak but non-neutral selection pressures, are introduced and applied to HIV-1. Our analysis of the molecular evolution of HIV-1 revealed that the (c/µ) of each nucleotide/amino acid site can be calculated to infer the overall site-specific selection fitness of the genome. In Chapter 2, the mutation rate µ is approximated independently of genetic codon tables and Markovian models by applying two complementary approaches: a time-based method using temporal sequence data and a position-based method leveraging genome-wide substitution rates. Using this framework, the c/µ test revealed an unexpected L-shaped distribution of fitness effects (DFE) and evidence of molecular clock violation across several genomic segments over 92 years of viral evolution. In Chapter 3, application of the codon-based c/µ method identified literature-validated adaptive mutations in Reverse Transcriptase, Protease, and Integrase, demonstrating the framework's ability to detect functionally relevant drug resistance mutations. Collectively, this work establishes a quantitative, multidisciplinary framework for understanding HIV-1 molecular evolution and provides insights that may inform future antiviral strategies and drug resistance detection efforts, as further validated through case studies on SARS-CoV-2 and EV68, demonstrating the framework's broader applicability to RNA viruses."],"dc:identifier":["https://rdw.rowan.edu/etd/3565"],"dc:title":["Using c/µ test to investigate the coding and noncoding regions to identify selective pressures in HIV-1 virus."],"thesis:degree_discipline":["Pharmaceutical Sciences"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["M.S. Pharmaceutical Sciences"]},"updated_at":"2026-11-19T09:00:08Z"}